GHK-Cu (100mg)
GHK-Cu (Copper Peptide) — 100mg | Research Grade | Australia
GHK-Cu is a naturally occurring tripeptide-copper complex first identified in human plasma. With one of the most established preclinical research profiles in the peptide field, it has been extensively investigated across regenerative biology, extracellular matrix dynamics, and inflammatory modulation in preclinical settings. Available from Austides in research-grade lyophilised form, third-party tested and domestically dispatched from Australia.
Research Applications
Examined in preclinical models for its role in stimulating collagen and elastin biosynthesis pathways in vitro
Studied for its influence on wound repair kinetics and dermal tissue regeneration mechanisms in animal models
Investigated in preclinical settings for antioxidant activity and modulation of inflammatory signalling cascades
Subject of preclinical research into hair follicle biology and follicular cycling mechanisms in animal models
Under active preclinical investigation for observed effects on neuronal protection pathways in vitro
Product Specifications
Sequence | Gly-His-Lys |
Molecular Weight | 340.38 g/mol |
CAS Number | 89030-95-5 |
Form | Lyophilised powder |
Purity | ≥99% (HPLC verified) |
Storage | Store at -20°C, away from light. Stable 24 months unopened. |
Austides Standard
All Austides peptides are third-party tested for purity and potency. Domestically dispatched from Australia with discrete, secure packaging and cold-chain integrity maintained throughout.
For research purposes only. Not for human consumption, therapeutic use, or self-administration. This product is not approved by the TGA for any therapeutic application.
){kind=link}